Business Context and Reporting Period
This Form 8-K is a current report filed by Aikido Pharma Inc. (not Dominari Holdings Inc.) on July 6, 2022. The report discloses a change in the company's independent registered public accounting firm effective July 5, 2022.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the administrative change of the external auditor.
Material Changes
- Dismissal of Auditor: The company dismissed WithumSmith+Brown, PC as its independent registered public accounting firm effective immediately on July 5, 2022.
- Engagement of New Auditor: The company engaged Marcum LLP as its new independent registered public accounting firm on July 5, 2022.
- Audit History: Withum audited the financial statements for the year ended December 31, 2021. Marcum previously served as the auditor for the fiscal year ended December 31, 2020.
Management Commentary and Risks
- No Disagreements: Management stated there were no disagreements with Withum regarding accounting principles, financial statement disclosures, or audit scope during the 2021 fiscal year or through the date of the report.
- No Reportable Events: There were no "reportable events" as defined by Regulation S-K during the relevant periods.
- Consultation with New Auditor: The company confirmed it did not consult Marcum regarding accounting principles, audit opinions, or matters involving disagreements prior to their engagement.
- Audit Opinion Status: The reports issued by Withum for the year ended December 31, 2021, contained no adverse opinions, disclaimers, or qualifications.
Investor Verification Checklist
- Verify the reasons for the auditor change by reviewing the letter from WithumSmith+Brown, PC filed as Exhibit 16.1.
- Confirm the transition timeline for the new auditor, Marcum LLP, to ensure continuity in future financial reporting.
- Review the most recent 10-K or 10-Q filings to obtain actual financial metrics (revenue, cash flow, etc.) which are absent in this 8-K.
- Monitor future filings for any restatements or qualifications related to the 2021 audit period.